Global Genitourinary Drugs Market Research Report 2024

Report ID: 1991156 | Published Date: Sep 2024 | No. of Page: 72 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Genitourinary Drugs Market Overview
    1.1 Product Overview and Scope of Genitourinary Drugs
    1.2 Genitourinary Drugs Segment by Type
        1.2.1 Global Genitourinary Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Urologicals
        1.2.3 Hormonal Therapy
        1.2.4 Gynecological
        1.2.5 Anti-infectives
    1.3 Genitourinary Drugs Segment by Application
        1.3.1 Global Genitourinary Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Prostate Cancer
        1.3.3 Ovarian Cancer
        1.3.4 Bladder Cancer
        1.3.5 Cervical Cancer
        1.3.6 Renal Cancer
        1.3.7 Erectile Dysfunction
        1.3.8 Urinary Tract Infections
        1.3.9 Urinary Incontinence & Overactive Bladder
        1.3.10 Sexually Transmitted Diseases
    1.4 Global Genitourinary Drugs Market Size Estimates and Forecasts
        1.4.1 Global Genitourinary Drugs Revenue 2017-2028
        1.4.2 Global Genitourinary Drugs Sales 2017-2028
        1.4.3 Genitourinary Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Genitourinary Drugs Market Competition by Manufacturers
    2.1 Global Genitourinary Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Genitourinary Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Genitourinary Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Genitourinary Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Genitourinary Drugs Market Competitive Situation and Trends
        2.5.1 Genitourinary Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Genitourinary Drugs Players Market Share by Revenue
        2.5.3 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genitourinary Drugs Retrospective Market Scenario by Region
    3.1 Global Genitourinary Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Genitourinary Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Genitourinary Drugs Market Facts & Figures by Country
        3.3.1 North America Genitourinary Drugs Sales by Country
        3.3.2 North America Genitourinary Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Genitourinary Drugs Market Facts & Figures by Country
        3.4.1 Europe Genitourinary Drugs Sales by Country
        3.4.2 Europe Genitourinary Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Genitourinary Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Genitourinary Drugs Sales by Region
        3.5.2 Asia Pacific Genitourinary Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Genitourinary Drugs Market Facts & Figures by Country
        3.6.1 Latin America Genitourinary Drugs Sales by Country
        3.6.2 Latin America Genitourinary Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Genitourinary Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Genitourinary Drugs Sales by Country
        3.7.2 Middle East and Africa Genitourinary Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Genitourinary Drugs Historic Market Analysis by Type
    4.1 Global Genitourinary Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Genitourinary Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Genitourinary Drugs Price by Type (2017-2022)
5 Global Genitourinary Drugs Historic Market Analysis by Application
    5.1 Global Genitourinary Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Genitourinary Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Genitourinary Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Novartis AG
        6.1.1 Novartis AG Corporation Information
        6.1.2 Novartis AG Description and Business Overview
        6.1.3 Novartis AG Genitourinary Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Novartis AG Genitourinary Drugs Product Portfolio
        6.1.5 Novartis AG Recent Developments/Updates
    6.2 Genentech
        6.2.1 Genentech Corporation Information
        6.2.2 Genentech Description and Business Overview
        6.2.3 Genentech Genitourinary Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Genentech Genitourinary Drugs Product Portfolio
        6.2.5 Genentech Recent Developments/Updates
7 Genitourinary Drugs Manufacturing Cost Analysis
    7.1 Genitourinary Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Genitourinary Drugs
    7.4 Genitourinary Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Genitourinary Drugs Distributors List
    8.3 Genitourinary Drugs Customers
9 Genitourinary Drugs Market Dynamics
    9.1 Genitourinary Drugs Industry Trends
    9.2 Genitourinary Drugs Market Drivers
    9.3 Genitourinary Drugs Market Challenges
    9.4 Genitourinary Drugs Market Restraints
10 Global Market Forecast
    10.1 Genitourinary Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Genitourinary Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Genitourinary Drugs by Type (2023-2028)
    10.2 Genitourinary Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Genitourinary Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Genitourinary Drugs by Application (2023-2028)
    10.3 Genitourinary Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Genitourinary Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Genitourinary Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Genitourinary Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Genitourinary Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Genitourinary Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Genitourinary Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Genitourinary Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Genitourinary Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Genitourinary Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Genitourinary Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Genitourinary Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Genitourinary Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Genitourinary Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Genitourinary Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Genitourinary Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Genitourinary Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Genitourinary Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Genitourinary Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Genitourinary Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Genitourinary Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Genitourinary Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Genitourinary Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Genitourinary Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Genitourinary Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Genitourinary Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Genitourinary Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Genitourinary Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Genitourinary Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Genitourinary Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Genitourinary Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Genitourinary Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Genitourinary Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Genitourinary Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Genitourinary Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Genitourinary Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Genitourinary Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Novartis AG Corporation Information
    Table 50. Novartis AG Description and Business Overview
    Table 51. Novartis AG Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Novartis AG Genitourinary Drugs Product
    Table 53. Novartis AG Recent Developments/Updates
    Table 54. Genentech Corporation Information
    Table 55. Genentech Description and Business Overview
    Table 56. Genentech Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Genentech Genitourinary Drugs Product
    Table 58. Genentech Recent Developments/Updates
    Table 59. Production Base and Market Concentration Rate of Raw Material
    Table 60. Key Suppliers of Raw Materials
    Table 61. Genitourinary Drugs Distributors List
    Table 62. Genitourinary Drugs Customers List
    Table 63. Genitourinary Drugs Market Trends
    Table 64. Genitourinary Drugs Market Drivers
    Table 65. Genitourinary Drugs Market Challenges
    Table 66. Genitourinary Drugs Market Restraints
    Table 67. Global Genitourinary Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 68. Global Genitourinary Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 69. Global Genitourinary Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 70. Global Genitourinary Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 71. Global Genitourinary Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 72. Global Genitourinary Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 73. Global Genitourinary Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 74. Global Genitourinary Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 75. Global Genitourinary Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 76. Global Genitourinary Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 77. Global Genitourinary Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 78. Global Genitourinary Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Genitourinary Drugs
    Figure 2. Global Genitourinary Drugs Market Share by Type in 2021 & 2028
    Figure 3. Urologicals Product Picture
    Figure 4. Hormonal Therapy Product Picture
    Figure 5. Gynecological Product Picture
    Figure 6. Anti-infectives Product Picture
    Figure 7. Global Genitourinary Drugs Market Share by Application in 2021 & 2028
    Figure 8. Prostate Cancer
    Figure 9. Ovarian Cancer
    Figure 10. Bladder Cancer
    Figure 11. Cervical Cancer
    Figure 12. Renal Cancer
    Figure 13. Erectile Dysfunction
    Figure 14. Urinary Tract Infections
    Figure 15. Urinary Incontinence & Overactive Bladder
    Figure 16. Sexually Transmitted Diseases
    Figure 17. Global Genitourinary Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Genitourinary Drugs Market Size (2017-2028) & (US$ Million)
    Figure 19. Global Genitourinary Drugs Sales (2017-2028) & (K Units)
    Figure 20. Genitourinary Drugs Sales Share by Manufacturers in 2021
    Figure 21. Global Genitourinary Drugs Revenue Share by Manufacturers in 2021
    Figure 22. The Global 5 and 10 Largest Genitourinary Drugs Players: Market Share by Revenue in 2021
    Figure 23. Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 24. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)
    Figure 25. Global Genitourinary Drugs Sales Market Share by Region in 2021
    Figure 26. Global Genitourinary Drugs Revenue Market Share by Region (2017-2022)
    Figure 27. Global Genitourinary Drugs Revenue Market Share by Region in 2021
    Figure 28. U.S. Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Canada Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Germany Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. France Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. U.K. Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Italy Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Russia Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. China Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Japan Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. South Korea Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. India Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Australia Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Taiwan Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Indonesia Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Thailand Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Malaysia Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Philippines Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Vietnam Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Mexico Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Brazil Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Argentina Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Turkey Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Saudi Arabia Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 51. UAE Genitourinary Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 52. Sales Market Share of Genitourinary Drugs by Type (2017-2022)
    Figure 53. Manufacturing Cost Structure of Genitourinary Drugs
    Figure 54. Manufacturing Process Analysis of Genitourinary Drugs
    Figure 55. Genitourinary Drugs Industrial Chain Analysis
    Figure 56. Channels of Distribution
    Figure 57. Distributors Profiles
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis AG
Genentech
Frequently Asked Questions
Genitourinary Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genitourinary Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genitourinary Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Geriatric Medicine

Geriatric Medicine market is segmented by players, region (country), by Type and by Application.  ... Read More

Gonorrhea Diagnostic

Gonorrhea Diagnostic market is segmented by players, region (country), by Type and by Application ... Read More